Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.72 EUR
−32.24 M EUR
0.00 EUR
30.44 M
About GH Research PLC
Sector
CEO
Velichka Valcheva
Headquarters
Dublin
Website
Founded
2021
ISIN
IE000GID8VI0
FIGI
BBG011XY1F00
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1KA is 6.65 EUR — it has decreased by −4.32% in the past 24 hours. Watch GH RESEARCH PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange GH RESEARCH PLC stocks are traded under the ticker 1KA.
1KA stock has fallen by −10.74% compared to the previous week, the month change is a −22.22% fall, over the last year GH RESEARCH PLC has showed a 35.71% increase.
We've gathered analysts' opinions on GH RESEARCH PLC future price: according to them, 1KA price has a max estimate of 37.76 EUR and a min estimate of 16.99 EUR. Watch 1KA chart and read a more detailed GH RESEARCH PLC stock forecast: see what analysts think of GH RESEARCH PLC and suggest that you do with its stocks.
1KA stock is 13.01% volatile and has beta coefficient of 1.32. Track GH RESEARCH PLC stock price on the chart and check out the list of the most volatile stocks — is GH RESEARCH PLC there?
Today GH RESEARCH PLC has the market capitalization of 350.09 M, it has decreased by −1.60% over the last week.
Yes, you can track GH RESEARCH PLC financials in yearly and quarterly reports right on TradingView.
GH RESEARCH PLC is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
1KA earnings for the last quarter are −0.21 EUR per share, whereas the estimation was −0.22 EUR resulting in a 6.50% surprise. The estimated earnings for the next quarter are −0.21 EUR per share. See more details about GH RESEARCH PLC earnings.
GH RESEARCH PLC revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1KA net income for the last quarter is −10.88 M EUR, while the quarter before that showed −9.69 M EUR of net income which accounts for −12.28% change. Track more GH RESEARCH PLC financial stats to get the full picture.
No, 1KA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2024, the company has 49.00 employees. See our rating of the largest employees — is GH RESEARCH PLC on this list?
Like other stocks, 1KA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GH RESEARCH PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GH RESEARCH PLC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GH RESEARCH PLC stock shows the sell signal. See more of GH RESEARCH PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.